Kezar Life Sciences Company
Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
South San Francisco, California, United States
Founded Date:
2015
Employees Number:
11-50
Funding Status:
IPO
Investors Number:
10
Total Funding:
$78.3M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series B
Register and Claim Ownership